Followers | 4051 |
Posts | 152184 |
Boards Moderated | 3 |
Alias Born | 08/05/2009 |
Thursday, July 27, 2023 1:14:29 PM
Recent FEMY News
- Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments • GlobeNewswire Inc. • 10/02/2024 12:30:00 PM
- Femasys Announces Infertility Clinic Customers from Coast to Coast • GlobeNewswire Inc. • 09/18/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 12:38:07 PM
- Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market • GlobeNewswire Inc. • 09/11/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 12:45:27 PM
- Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check • GlobeNewswire Inc. • 09/09/2024 12:30:00 PM
- Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting • GlobeNewswire Inc. • 09/05/2024 12:30:00 PM
- Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:31:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 01:15:35 PM
- Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution • GlobeNewswire Inc. • 08/29/2024 12:30:00 PM
- Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters • GlobeNewswire Inc. • 08/27/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 12:45:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:35:40 PM
- Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update • GlobeNewswire Inc. • 08/08/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:39:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:37:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:34:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:33:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 08:01:44 PM
- Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam • GlobeNewswire Inc. • 06/27/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:49:26 PM
- Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe • GlobeNewswire Inc. • 06/20/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/07/2024 08:01:11 PM
- Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative • GlobeNewswire Inc. • 05/17/2024 12:30:00 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM